The RBM8A gene helps cells process RNA, the message they use to build proteins. This gene plays an important role in normal growth and in making blood cells, especially platelets, which help stop bleeding. When the RBM8A gene does not work properly, some people can have TAR syndrome, a condition linked to low platelet counts and missing or underdeveloped forearm bones.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, the parts of cells that do the work. Other genes mainly direct when certain activities happen, where they take place, and how active they are. Together, genes affect how your body develops and functions, and they may influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
RBM8AGene function
What if the gene works
The RBM8A gene helps cells process messenger RNA, the working copy of genetic instructions. This supports normal protein production and steady growth and division, especially during early development.
Risk
What if the gene does not work
Reduced activity of the RBM8A gene is best known for TAR syndrome, which combines low platelet counts with absent radii. Milder and more severe variants can affect how early problems appear and how strongly blood and limb features show up.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the RBM8A gene does not currently point to a gene-specific treatment or guide medication choice. Care is based on the person’s symptoms and standard supportive treatment, while the RBM8A gene is also being studied in cancer research as a possible biomarker and drug target.
Conditions associated with RBM8A
Gene function
What if the gene works
Your cells need clear working copies of DNA instructions every day. The RBM8A gene helps manage RNA, the temporary message cells read to make proteins. Understanding what the RBM8A gene does helps explain how cells prepare those messages and use them in the right place.
The RBM8A gene helps mark RNA after it has been cut and joined into its final message. This mark tells the cell that the message has been properly processed and is ready for the next steps.
Its protein helps cells spot RNA messages that carry an early stop signal. When needed, this supports nonsense mediated decay (a cleanup system that removes incomplete messages) so protein instructions stay accurate.
RBM8A also helps guide finished RNA messages out of the nucleus, where DNA is stored, into the main part of the cell. This helps protein making happen in the right place and at the right time.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In TAR syndrome, variants in the RBM8A gene usually reduce how much RBM8A protein a cell can make. Many people carry one more disruptive variant that removes function from one copy and one milder regulatory variant that turns down the other copy, leaving too little protein for accurate handling of genetic messages inside cells. Milder combinations may leave more residual activity, while larger drops in protein level can be linked to earlier or more marked features.
How variants are linked to conditions
Variants involving the RBM8A gene are best established as a cause of thrombocytopenia-absent radius syndrome (TAR syndrome), the main RBM8A gene and TAR syndrome link described in clinical genetics. People with this condition are born with low platelets and missing radius bones in the forearms, though severity can vary. TAR syndrome usually reflects a specific combination of RBM8A variants rather than one common change alone.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found across the population. Most do not directly affect health and instead represent normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For RBM8A, risk is mainly shaped by the exact genetic changes inherited, especially a disease-causing change together with a low-activity RBM8A change. Lifestyle habits are not known to meaningfully change the chance of having this condition, but family history can affect the chance for future children or relatives.
Inheritance of RBM8A variants
RBM8A-related TAR syndrome follows an autosomal recessive pattern. In practice, RBM8A inheritance usually means a child inherits two RBM8A changes, most often one more disruptive RBM8A variant from one parent and one low-expression RBM8A variant from the other parent. Parents are often unaffected carriers. When both parents carry the needed RBM8A changes, each pregnancy has a 25% chance of TAR syndrome, a 50% chance of being a carrier, and a 25% chance of inheriting neither disease-causing combination. Sons and daughters are affected equally.
What does my RBM8A result mean for my family?
For families affected by an RBM8A-related condition, parents are often healthy carriers, and brothers or sisters may also be affected or carry the same change. Close relatives may also carry an RBM8A change without knowing it. The exact family impact can depend on the specific result, because this gene is usually linked to a rare pattern where two different kinds of changes are inherited together.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the RBM8A gene, a lab can analyze DNA from a blood sample or cheek swab. Genetic testing for RBM8A variants reads the gene's code and looks for changes, often as part of a broader panel or exome test. Results may need expert interpretation.
When should I consider getting a genetic test?
Genetic testing for the RBM8A gene is usually considered when a baby or child has signs of TAR syndrome, a condition that can cause very low platelet counts and missing or underdeveloped forearm bones. It can also help when TAR syndrome runs in the family or for pregnancy planning after an affected child.
A genetic result is only one part of your health story
A genetic finding can provide helpful insight, but how much it explains depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. Because of this, the same medication may work better for some people, have less effect in others, or cause more side effects in those who are more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies relationships between genes and medications to help explain why the same treatment can work differently in different people. With many drugs, genes can influence how strongly a medicine works or how the body handles it. This information can support better informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the RBM8A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about side effects, new symptoms, or how a treatment is working are best discussed with your doctor.
History
The RBM8A gene entered medical genetics through basic research on how cells handle RNA, the working copies made from DNA. In the late 1990s and early 2000s, scientists identified its protein, often called Y14, as part of a group that helps process RNA after genes are read. Building on this early work, scientists uncovered more about the gene when RBM8A was linked to thrombocytopenia-absent radius syndrome, a rare inherited condition affecting platelet counts and arm development. That finding was especially important because it showed that the condition can result from a combination of a rare RBM8A variant and a common regulatory change that lowers gene activity. This helped widen genetic thinking beyond single, fully disruptive variants and added an important chapter to the study of inherited conditions.